Brooks O, Bach P, Dong H, Milloy MJ, Fairbairn N, Kerr T, Hayashi K Crystal methamphetamine use subgroups and associated addiction care access and overdose risk in a Canadian urban setting Drug Alcohol Depend, 2022. PubMed


Pilarinos A, Bromberg DJ, Karamouzian M Access to medications for opioid use disorder and associated factors among adolescents and young adults: a systematic review JAMA Pediatr, 2022. PubMed


Hamilton J, Ti L, Korchinski M, Nolan S Peer support specialists: an underutilized resource in the criminal justice system for opioid use disorder management? J Addict Med, 2022. PubMed


Klimas J, Hamilton MA, Carney G, Cooper IR, Croteau NS, Dong H, Dormuth C, Maclure M, Socías ME, Ti L, Wood E, McCracken R Characteristics and incidence of opioid analgesic initiations to opioid naïve patients in a Canadian primary care setting Can J Addict, 2022. Link


Meyers-Pantele S, Jain S, Sun X, Marks C, DeBeck K, Hayashi K, Strathdee S, Werb D Gender and the first-time provision of injection initiation assistance among people who inject drugs across two distinct North American contexts: Tijuana, Mexico and Vancouver, Canada Drug Alcohol Rev, 2022. PubMed


Shearer D, Young S, Fairbairn N, Brar R Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series Drug Alcohol Rev, 2022. PubMed


van Draanen J, Satti S, Morgan J, Gaudette L, Knight R, Ti L Using passive surveillance technology for overdose prevention: key ethical and implementation issues Drug Alcohol Rev, 2022. PubMed


Argento E, Socías ME, Hayashi K, Choi JC, Mackay L, Christie D, Milloy MJ, DeBeck K Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting Int J Drug Policy, 2022. PubMed


Wilson T, Pitcher I, Bach P Avoidance of β-blockers in patients who use stimulants is not supported by good evidence CMAJ, 2022. PubMed


Tobias S, Lysyshyn M, Buxton J, Tupper KW, Ti L Tobias et al. respond to "Novel surveillance of the unregulated drug supply" Am J Epidemiol, 2022. PubMed


BC Centre on Substance Use
4th Floor, 1190 Hornby Street,
Vancouver BC, V6Z 2K5

E: [email protected] | T: (778) 945-7616

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2026, BC Centre on Substance Use